bpc 157 peptide used for BPC-157 FDA Approval Status: Is It Approved Human Use? BPC-157 – Research Peptide |

[5] Disruption of these pathways leads to accumulation of homocysteine and methylmalonic acid, metabolic signatures linked to megaloblastic anemia and demyelinating neuropathy

Unexplained persistent high B12 levels should prompt evaluation for these conditions

After initial recovery, doses are typically reduced to maintenance levels (5001,000 IU 3/week)

19 References Seiwerth, S., Sikiric, P., Grabarevi, ., Zorii, I., Hanevaki, M., Ljubanovi, D., ori, V., Konjevoda, P., Petek, M., Ruman, R., Turkovi, B., Perovi, D., Mikus, D., Jandrijevi, S., Medvidovi, M., Tadi, T., Romac, B., Kos, J., Peri, J., & Kolega, Z

This provides backup if questions or concerns arise